Proceedings: Trazodone: clinical and biochemical studies I. An uncontrolled clinical trial in depression. 1976

J C Pecknold, and S Putzolu, and T A Ban

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014196 Trazodone A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309) AF-1161,Apo-Trazodone,Deprax,Desyrel,Gen-Trazodone,Molipaxin,Novo-Trazodone,Nu-Trazodone,PMS-Trazodone,Ratio-Trazodone,Thombran,Tradozone,Trazodon Hexal,Trazodon-Neuraxpharm,Trazodone Hydrochloride,Trazon,Trittico,AF 1161,AF1161,Apo Trazodone,Gen Trazodone,Novo Trazodone,Nu Trazodone,PMS Trazodone,Ratio Trazodone,RatioTrazodone,Trazodon Neuraxpharm,TrazodonNeuraxpharm

Related Publications

J C Pecknold, and S Putzolu, and T A Ban
January 1976, Psychopharmacology bulletin,
J C Pecknold, and S Putzolu, and T A Ban
January 1992, Journal of child and adolescent psychopharmacology,
J C Pecknold, and S Putzolu, and T A Ban
February 1988, Archives of general psychiatry,
J C Pecknold, and S Putzolu, and T A Ban
January 1980, International pharmacopsychiatry,
J C Pecknold, and S Putzolu, and T A Ban
August 1973, Current therapeutic research, clinical and experimental,
J C Pecknold, and S Putzolu, and T A Ban
January 1976, Psychopharmacology bulletin,
J C Pecknold, and S Putzolu, and T A Ban
January 1976, Psychopharmacology bulletin,
J C Pecknold, and S Putzolu, and T A Ban
January 1976, Psychopharmacology bulletin,
J C Pecknold, and S Putzolu, and T A Ban
November 1967, The Journal of clinical investigation,
Copied contents to your clipboard!